Market Overview

The Global Psoriasis Drugs Market was valued at USD 14,912.6 million in 2023 and is expected to reach USD 26,399.0 million by 2031 while growing at a CAGR of 7.4% during the forecast period (2024-2031).

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Market Dynamics

This section of the report will analyze various driving and restraining factors that are expected to have a significant impact on the global psoriasis drugs market growth. Psoriasis, an autoimmune skin condition, induces itchiness and discomfort, with plaque psoriasis being its predominant form, characterized by thick, scaly patches of skin. Although no cure exists, treatment options are available to alleviate symptoms. Your healthcare provider may recommend specialized creams or ointments for managing psoriasis.

The rise in psoriasis prevalence, coupled with growing patient awareness and treatment-seeking behavior, along with advancements in drug delivery technologies like biologics and targeted therapies, propel market growth. However, challenges such as the high cost of treatment and safety concerns and side effects impede market expansion.

Furthermore, the global psoriasis drugs industry will be analyzed through various tools including PESTLE analysis, and Porter’s analysis.

Segmentation – By Product Type Analysis

The Global Psoriasis Drugs Market is segmented among Topical Psoriasis Drugs, Oral Psoriasis Drugs, Injectable Psoriasis Drugs, based on Product Type. In 2023, Oral Psoriasis Drugs accounted for the majority of the market share*.

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Segmentation – By Drug Class Analysis

The Global Psoriasis Drugs Market is segmented among Interleukin Inhibitors, Corticosteroids, Anti-inflammatory, and Tumor Necrosos Factor Inhibitors, based on Drug Class. In 2023, Interleukin Inhibitors accounted for the majority of the market share*.

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Global Psoriasis Drugs Market: Regional Analysis

Based on region, the market is divided into six regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. In 2023, North America dominated the market with the highest market share, while Asia Pacific is expected to grow with the highest CAGR during the forecast period (2024 – 2031).

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Competitive Landscape

Some of the key players operating in the market are Amgen Inc., Eli Lily and Company, Novartis, Johnsom & Johnson, AstraZeneca Plc, LEO Pharma AS, Biogen Inc, Sun Pharmaceuticals Industries, Pfizer, Celgene Corporation, Merck.

Table of Contents:

1. Research Methodology and Market Scope

• Research Methodology

• Market Scope

2. Executive Summary

3. Global Psoriasis Drugs Market Dynamics

• Drivers

• Restraints

• Opportunity

4. Global Psoriasis Drugs Industry Analysis

• PEST Analysis

• Porter's Five Force Analysis

• Recent Deals Analysis

5. Global Psoriasis Drugs Market Segmentation, By Product Type

• Global Psoriasis Drugs Market Share Analysis, By Product Type

• Global Psoriasis Drugs Market Growth Analysis, By Product Type

• Global Psoriasis Drugs Market Trends, By Product Type

o Topical Psoriasis Drugs

o Oral Psoriasis Drugs

o Injectable Psoriasis Drugs

6. Global Psoriasis Drugs Market Segmentation, By Drug Class

• Global Psoriasis Drugs Market Share Analysis, By Drug Class

• Global Psoriasis Drugs Market Growth Analysis, By Drug Class

• Global Psoriasis Drugs Market Trends, By Drug Class

o Interleukin Inhibitors

o Corticosteroids

o Anti-inflammatory

o Tumor Necrosos Factor Inhibitors

7. Global Psoriasis Drugs Market Segmentation, By Distribution Channel

• Global Psoriasis Drugs Market Share Analysis, By Distribution Channel

• Global Psoriasis Drugs Market Growth Analysis, By Distribution Channel

• Global Psoriasis Drugs Market Trends, By Distribution Channel

o Hospital Pharmacies

o Retail Pharmacies

o E-Commerce

8. Global Psoriasis Drugs Market Segmentation, By Region

• Global Psoriasis Drugs Market Share Analysis, By Region

• Global Psoriasis Drugs Market Growth Analysis, By Region

• Global Psoriasis Drugs Market Trends, By Region

o North America

o Europe

o Asia Pacific

o Latin America

o Middle East

o Africa

9. Competitive Landscape

• Amgen Inc*

o Company Overview

o Financial Performance

o Key Development/Strategies

o SWOT Analysis

• Eli Lily and Company

• Novartis

• Johnsom & Johnson

• AstraZeneca Plc

• LEO Pharma AS

• Biogen Inc

• Sun Pharmaceuticals Industries

• Pfizer

• Celgene Corporation

• Merck

*Similar analysis will be provided for each company listed above.